SCHEDULE 13G/A: Investment Funds Correct Jaguar Health Stake Disclosure in Amended SEC Filing
Schedule 13G Amendment
CVI Investments, Inc. and Heights Capital Management, Inc. filed an amended Schedule 13G to correct an administrative error, disclosing a beneficial ownership of 9.9% in Jaguar Health, Inc.
Summary
- CVI Investments, Inc. and Heights Capital Management, Inc. filed an Amendment No. 1 to Schedule 13G for Jaguar Health, Inc.
- The amendment corrects an administrative error in the previously filed Schedule 13G on May 28, 2025, which underreported the number of shares owned by the Reporting Persons.
- The Reporting Persons, CVI Investments, Inc. and Heights Capital Management, Inc., beneficially own an aggregate of 131,249 shares of Jaguar Health, Inc. common stock.
- This ownership represents 9.9% of Jaguar Health, Inc.'s common stock.
- The beneficially owned shares consist of 82,102 direct shares and additional shares issuable upon the exercise of warrants.
- Warrants are not exercisable if beneficial ownership would exceed 9.99% of the outstanding shares.
- As of the completion of a recent offering, Jaguar Health, Inc. had 1,264,658 shares outstanding (excluding shares underlying warrants), as indicated in its Prospectus Supplement filed on May 22, 2025.
- Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and exercises shared voting and dispositive power over the reported shares.
Sentiment
Score: 5
Explanation: The document is neutral as it is a corrective filing addressing an administrative error in a previous disclosure, rather than announcing new financial performance or strategic initiatives.
Negatives
- An administrative error led to the underreporting of shares in the initial Schedule 13G filing, necessitating this amendment.
Risks
- The filing explicitly states that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer, mitigating concerns about activist investor intentions.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of significant beneficial ownership, common in the investment industry. It does not provide broader industry trends but reflects an investment firm's position in a specific company within the healthcare or pharmaceutical sector (given Jaguar Health's typical business).
Stakeholder Impact
- Shareholders: Provides updated and accurate information regarding significant beneficial ownership, ensuring transparency.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of event which requires filing of this statement. |
| 05/22/2025 | Date of Jaguar Health, Inc.'s Prospectus Supplement indicating 1,264,658 shares outstanding. |
| 05/28/2025 | Date of the original Schedule 13G filing and the current Amendment No. 1 filing. |
Keywords
Jaguar Health Inc., CVI Investments Inc., Heights Capital Management Inc., Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Management, Warrants, Shareholding Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.